JKJyoti Maithani Kalra

Jyoti Maithani Kalra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jyoti Maithani Kalra has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Granulocyte-macrophage colony-stimulating factor (GM-CSF) in inflammatory lung diseases: pathogenic contributor and therapeutic target

    by Muhammad Afzal, Sami I. Alzarea, Imran Kazmi, Abida Khan, Surya Nath Pandey, Arcot Rekha, Rakhi Mishra, Deepika Raina, Jyoti Maithani Kalra, Kapil Kalra, et al.

    Granulocyte-macrophage colony-stimulating factor (GM-CSF) is an integral pathogenic factor in inflammatory lung pathologies including asthma, COPD, and lung cancer. As a pro-inflammatory cytokine, GM-CSF triggers the division and stimulation of granulocytes and macrophages, exacerbating the inflammatory response and promoting lung tissue damage. GM-CSF is an essential factor in promoting the production of the corresponding cytokines, levelling the effect of local activity by stimulating the infiltration of immune cells and maintaining chronic inflammation. Therefore, its neutralization in many ways leads to the cessation of the progression and exacerbation of inflammation in the lungs of patients with corresponding pathologies. Inhibitory therapy associated with GM-CSF reduces the number of immune cells and activates them at the inflammatory focus. The use of neutralizing antibodies to treat an acute inflammatory process is promising because they relatively quickly neutralize the effect of pathogenic GM-CSF. However, the immunocyte response can also be inhibited at the level of formation. Therapy with GM-CSF inhibitors can significantly reduce acute inflammation but can lead to adverse changes in the innate immunity of the patient. This review highlights GM-CSF's dual function of GM-CSF as a pathogenic contributor and possible treatment targets.

  • Open Access

    Explainable Machine Learning Using Taguchi-QbD Data for Digital Design Space Mapping of Pregabalin Extended-Release Tablets

    by Deepender, Tarandeep Singh Walia, Sreenath Sriram, Nabeel Ahmad, Sonal Solanki, Nikunj Solanki, Jyoti Maithani Kalra, Yamsani Shravan, Sreekanth Thota, Kapil Kalra, et al.

    This study applied explainable machine learning to published Taguchi-QbD data for pregabalin extended-release tablets to support formulation understanding and digital design space mapping. No new experimental batches were prepared; the analysis used formulation-response data from a previously developed pregabalin extended-release tablet system. A secondary data set containing 16 Taguchi formulations was prepared using six formulation and process variables: lipid material type, lipid quantity, hydrophilic matrix type, hydrophilic matrix quantity, filler type, and compression force. Hardness, friability, and dissolution at 1, 2, 4, and 8 h were selected as modeling responses. Ridge regression, random forest regression, extra trees regression, and Gaussian process regression were evaluated using leave-one-out cross-validation. Model-independent explainability was performed using permutation feature importance, partial dependence analysis, and surrogate decision-tree rules. A desirability-based virtual formulation screening approach was then used to identify high-desirability regions within the original experimental design limits. Dissolution at 2 h and 4 h showed the most useful cross-validated predictive performance, with mean absolute errors of 10.25% and 8.10%, respectively. Explainability analysis identified hydrophilic matrix quantity as the dominant variable controlling early and intermediate drug release, whereas lipid type and lipid quantity were more influential for tablet hardness and late-stage release behavior. Among the original Taguchi formulations, F15 showed the highest observed desirability, although it did not fully satisfy all dissolution criteria. Virtual screening identified high-desirability in silico candidates characterized mainly by high hydrophilic matrix loading and adequate lipid content. The published optimized formulation was positioned within a high-desirability AI-predicted region, supporting consistency between the explainable ML workflow and the original QbD optimization. These findings indicate that small-data explainable machine learning can complement QbD-based formulation analysis by extracting formulation rules and prioritizing design-space regions; however, AI-predicted candidates require experimental confirmation.

  • Open Access

    Machine Learning Modeling of D-Optimal Design Data for Metformin Hydrochloride Orally Disintegrating Tablets

    by Sanju, Suresh Yarlagadda, Vinay Kumar, Sreenath Sriram, Nabeel Ahmad, Sonal Solanki, Nikunj Solanki, Jyoti Maithani Kalra, Yamsani Shravan, Sreekanth Thota, et al.

    Metformin hydrochloride orally disintegrating tablets require an appropriate balance between mechanical strength and rapid disintegration, particularly because the drug is administered at a relatively high dose and has unfavorable taste characteristics. The present study applied machine learning to published D-optimal design data for metformin hydrochloride orally disintegrating tablets to evaluate whether formulation and process variables could predict powder-flow and tablet-performance responses. The dataset contained 30 experimental runs with four inputs: co-processed metformin hydrochloride ratio, co-processed excipient ratio, compression pressure, and excipient brand. Five responses were modeled separately: angle of repose, Hausner’s ratio, Carr’s index, hardness, and disintegration time. Polynomial Ridge Regression, Random Forest, Extra Trees, Gradient Boosting, Support Vector Regression, Gaussian Process Regression, and k-nearest neighbors were compared using leave-one-out cross-validation. Model performance was assessed using mean absolute error, root mean square error, and cross-validated R². Gaussian Process Regression was the best model for Hausner’s ratio, Carr’s index, hardness, and disintegration time, while Support Vector Regression performed best for angle of repose. Tablet hardness and disintegration time were predicted with the strongest performance, with R² values of 0.840 and 0.858, respectively. In contrast, angle of repose was weakly predicted, with an R² of 0.158. Permutation importance and partial dependence analysis indicated that compression pressure and excipient brand were the main contributors to tablet-level responses. The findings show that machine learning can support interpretation of D-optimal formulation data, especially for tablet-performance attributes, while predictions remain limited by dataset size and absence of new external validation.


  • Open Access

    QSAR of acyl alizarin red biocompound derivatives of Rubia tinctorum roots and its ADMET properties as anti-breast cancer candidates against MMP-9 protein receptor: In Silico study

    by M. R.T. Alifiansyah, M. A. Herdiansyah, R. C. Pratiwi, R. P. Pramesti, N. W. Hafsyah, A. P. Rania, Ju. E.R.P. Putra, P. A. Cahyono, Litazkiyyah, S. K. Muhammad, et al.

    Alizarin is a polycyclic compound isolated from roots of Rubia tinctorum that has potential as a breast anticancer candidate. Increasing anticancer activity can be done through structural modification to produce derivatives in the form of group substitution in the meta position using acyl. The purpose of this work is to forecast the anticancer activity of alizarin and its derivatives on the MMP-9 receptor using. Important biological activity factors will be identified by Quantitative Structure Activity molecular docking Relationship (QSAR) and projected absorption, distribution, metabolism, elimination, and toxicity (ADMET). Using Molegro Virtual Docker (MVD), molecular docking was carried out on the MMP 9 receptor (4WZV.pdb). LogP, Etot, and MR are the physicochemical parameters that are examined in order to produce QSAR. Statistical Package for the Social Science (SPSS) was used for the QSAR analysis. The pkCSM was utilized to determine ADMET prediction. The acyl alizarin derivatives have a lower rerank score than alizarin, according to the docking results so that they are predicted to have more potent anticancer activity. The QSAR analysis's findings indicated that logP and Etot had the greatest effects on the alizarin compound's and its derivatives' activity. The results of the ADMET prediction indicate that acyl alizarin is less harmful and superior to alizarin. Research findings show that it is possible to synthesize acyl alizarin derivatives, especially alizarin octanoate, which will then be tested in vitro or in vivo to determine its anti-breast cancer activity and toxicity.